non-malignant esophageal stenosis (esophageal narrowing)/ esophageal perforation (leak)
Conditions
Interventions
stent insertion --> Ultraflex stent or Hanarostent
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients, 18 years of age and older, referred for stent placement for benign esophageal disease.
Exclusion criteria
Exclusion criteria: Presence of an esophageal malignancy or extrinsic compression due to mediastinal malignancy. Location of lesions at less than 4 cm from upper gastro-intestinal sphincter. Lesions longer than 9 cm. Patients who are unable to undergo endoscopy
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| o Technical outcome - defined as success of stent deployment at the required position. o Immediate functional outcome - defined as immediate clinical success in relief of dysphagia, or sealing of a perforation or fistula at 24 hours. o Re-intervention rate after stent removal. o Procedural complications. o Success of stent extraction. o Thirty-day mortality rate. | — |
Primary
| Measure | Time frame |
|---|---|
| The primary parameter of this study is the stent migration rate. | — |
Countries
Netherlands
Outcome results
None listed